a recent clinical trial of controlled-release carbidopa/levodopa preparation afforded us the opportunity to examine the effects of chronically increasing circulating 3-o-methyldopa ( omd ) levels on the clinical response to levodopa .
C0353697
carbidopa/levodopa
C0023570
levodopa